0001493152-26-018593.txt : 20260422 0001493152-26-018593.hdr.sgml : 20260422 20260422172314 ACCESSION NUMBER: 0001493152-26-018593 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260422 DATE AS OF CHANGE: 20260422 EFFECTIVENESS DATE: 20260422 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hepion Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001583771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 462783806 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-581512 FILM NUMBER: 26884804 BUSINESS ADDRESS: STREET 1: 34 SHREWSBURY AVE. STREET 2: SUITE 1D CITY: RED BANK STATE: NJ ZIP: 07701 BUSINESS PHONE: 732-902-4000 MAIL ADDRESS: STREET 1: 34 SHREWSBURY AVE. STREET 2: SUITE 1D CITY: RED BANK STATE: NJ ZIP: 07701 FORMER COMPANY: FORMER CONFORMED NAME: ContraVir Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20130806 D 1 primary_doc.xml X0708 D LIVE 0001583771 Hepion Pharmaceuticals, Inc. 34 SHREWSBURY AVE. SUITE 1D RED BANK NJ NEW JERSEY 07701 (732) 902-4000 DELAWARE None ContraVir Pharmaceuticals, Inc. Corporation true Gary Stetz 34 Shrewsbury Ave. Suite 1D Red Bank NJ NEW JERSEY 07701 Executive Officer Director Interim Chief Executive Officer Vincent LoPriore 34 Shrewsbury Ave. Suite 1D Red Bank NJ NEW JERSEY 07701 Executive Officer Director Executive Chairman Sireesh Appajosyula 34 Shrewsbury Ave. Suite 1D Red Bank NJ NEW JERSEY 07701 Director Chase LoPriore 34 Shrewsbury Ave. Suite 1D Red Bank NJ NEW JERSEY 07701 Director Michael Purcell 34 Shrewsbury Ave. Suite 1D Red Bank NJ NEW JERSEY 07701 Director Timothy Block 34 Shrewsbury Ave. Suite 1D Red Bank NJ NEW JERSEY 07701 Director Biotechnology Decline to Disclose 06b false 2026-04-21 false true false 0 700000 700000 0 false 11 0 0 700000 false Hepion Pharmaceuticals, Inc. /s/ Gary Stetz Gary Stetz Interim Chief Executive Officer 2026-04-22